SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms
- PMID: 34040615
- PMCID: PMC8141918
- DOI: 10.3389/fimmu.2021.674922
SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms
Abstract
Since December 2019, the world has been facing an outbreak of a new disease called coronavirus disease 2019 (COVID-19). The COVID-19 pandemic is caused by a novel beta-coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 infection mainly affects the respiratory system. Recently, there have been some reports of extra-respiratory symptoms such as neurological manifestations in COVID-19. According to the increasing reports of Guillain-Barré syndrome following COVID-19, we mainly focused on SARS-CoV-2 infection and Guillain-Barré syndrome in this review. We tried to explain the possibility of a relationship between SARS-CoV-2 infection and Guillain-Barré syndrome and potential pathogenic mechanisms based on current and past knowledge.
Keywords: COVID-19; Coronavirus; Guillain-Barré syndrome; Neurological manifestations; SARS-CoV-2.
Copyright © 2021 Shoraka, Ferreira, Mohebbi and Ghaemi.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.Rev Neurol (Paris). 2021 Jan-Feb;177(1-2):51-64. doi: 10.1016/j.neurol.2020.10.001. Epub 2020 Dec 16. Rev Neurol (Paris). 2021. PMID: 33446327 Free PMC article. Review.
-
Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.J Mol Neurosci. 2021 Nov;71(11):2192-2209. doi: 10.1007/s12031-020-01767-6. Epub 2021 Jan 19. J Mol Neurosci. 2021. PMID: 33464535 Free PMC article. Review.
-
Neurological Involvements of SARS-CoV2 Infection.Mol Neurobiol. 2021 Mar;58(3):944-949. doi: 10.1007/s12035-020-02070-6. Epub 2020 Oct 16. Mol Neurobiol. 2021. PMID: 33064267 Free PMC article. Review.
-
Emerging neurotropic features of SARS-CoV-2.J Mol Cell Biol. 2021 Dec 30;13(10):705-711. doi: 10.1093/jmcb/mjab044. J Mol Cell Biol. 2021. PMID: 34289037 Free PMC article. Review.
-
Review article on COVID-19 and Guillain-Barré syndrome.Front Biosci (Schol Ed). 2021 Jun 30;13(1):97-104. doi: 10.52586/S555. Front Biosci (Schol Ed). 2021. PMID: 34256532 Review.
Cited by
-
Guillain-Barré Syndrome Associated With COVID-19 Infection: A Case Report and Review of Pathophysiology, Risk Factors, and Management.Cureus. 2025 Jun 5;17(6):e85414. doi: 10.7759/cureus.85414. eCollection 2025 Jun. Cureus. 2025. PMID: 40621321 Free PMC article.
-
Identifying potential co-expressed genes and molecular mechanisms linking post-COVID-19 and Guillain-Barre syndrome through neutrophil extracellular trap-related genes.Front Neurol. 2025 May 13;16:1447725. doi: 10.3389/fneur.2025.1447725. eCollection 2025. Front Neurol. 2025. PMID: 40433617 Free PMC article.
-
Neurological manifestation in COVID-19 disease with neuroimaging studies.Am J Neurodegener Dis. 2023 Apr 15;12(2):42-84. eCollection 2023. Am J Neurodegener Dis. 2023. PMID: 37213710 Free PMC article. Review.
-
Guillain-Barré Syndrome Associated with COVID-19 in a Japanese Male.Case Rep Neurol Med. 2022 Oct 22;2022:6837851. doi: 10.1155/2022/6837851. eCollection 2022. Case Rep Neurol Med. 2022. PMID: 36316995 Free PMC article.
-
Long non-coding RNAs ANRIL, THRIL, and NEAT1 as potential circulating biomarkers of SARS-CoV-2 infection and disease severity.Virus Res. 2023 Oct 15;336:199214. doi: 10.1016/j.virusres.2023.199214. Epub 2023 Sep 11. Virus Res. 2023. PMID: 37657511 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous